Latest Interventional cardiology Stories

Berlin Heart EXCOR® Pediatric Finalist for the 2012 Prix Galien Award

2012-08-13 02:25:16

THE WOODLANDS, Texas, Aug. 13, 2012 /PRNewswire/ -- Berlin Heart announced today that the EXCOR® Pediatric Ventricular Assist Device (VAD) has been chosen by Prix Galien USA as a finalist for the 2012 Prix Galien Award; Category: Best Medical Technology Product. The Prix Galien Awards were created to honor medical research and pharmacology for outstanding efforts to improve the human condition through approval of innovative treatments and medicines. (Logo:...

HeartWare Presentation At The Canaccord Genuity 32nd Annual Growth Conference To Be Webcast

2012-08-10 02:23:12

FRAMINGHAM, Mass. and SYDNEY, Aug. 10, 2012 /PRNewswire/ -- HeartWare International, Inc. (NASDAQ: HTWR - ASX: HIN), a leading innovator of less invasive, miniaturized circulatory support technologies that are revolutionizing the treatment of advanced heart failure, today announced that CEO Doug Godshall is scheduled to present at the Canaccord Genuity 32(nd) Annual Growth Conference at 8:00 a.m. EDT on Wednesday, August 15, 2012. The conference is being held August 14-16, 2012 at...

HeartWare Presentation at the 2012 Wedbush PacGrow Lifesciences Management Access Conference to be Webcast

2012-08-09 10:26:21

FRAMINGHAM, Mass. and SYDNEY, Aug. 9, 2012 /PRNewswire/ -- HeartWare International, Inc. (NASDAQ: HTWR - ASX: HIN), a leading innovator of less invasive, miniaturized circulatory support technologies that are revolutionizing the treatment of advanced heart failure, today announced that CEO Doug Godshall is scheduled to present at the 2012 Wedbush PacGrow Lifesciences Management Access Conference at 9:10 a.m. EDT on Tuesday, August 14, 2012. The conference is being held August...

Berlin Heart's EXCOR® Pediatric Ventricular Assist Device (VAD) Post Approval Study Protocol Approved

2012-08-06 10:23:49

THE WOODLANDS, Texas, Aug. 6, 2012 /PRNewswire/ -- The Berlin Heart Group announced today that the FDA has granted approval for their Post Approval Study, a condition of the "Humanitarian Device Exemption" (HDE) approval that Berlin Heart received for the EXCOR(®) Pediatric Ventricular Assist Device (VAD) on December 16(th), 2011. (Logo: http://photos.prnewswire.com/prnh/20120806/DA52722LOGO) The Berlin Heart EXCOR® Pediatric VAD is a mechanical cardiac support system for...

genae Appoints Core Lab Directors

2012-08-01 06:24:47

CLEVELAND, August 1, 2012 /PRNewswire/ -- genae,a leading Contract Research Organization (CRO) and services provider for the medical device industries, today announced the appointment of Dr. Marco Costa and Dr. Hiram Grando Bezerra as Core Lab Directors. In their role, Dr. Costa and Dr. Bezerra will be responsible for the liaison with the study sponsors, the presentation at investigator meetings and the design and quality control & assurance of the image analysis...

Cardiovascular Devices Market: 2018 Outlook for Cardiac Rhythm Management, Interventional Cardiology, Peripheral Vascular Devices, Electrophysiology, Prosthetic Heart Valves and Others

2012-07-30 02:25:29

DALLAS, July 30, 2012 /PRNewswire/ -- ReportsnReports.com adds new market research reports on Cardiovascular Devices Market Outlook to 2018 - Cardiac Rhythm Management, Interventional Cardiology, Peripheral Vascular Devices, Electrophysiology Prosthetic Heart Valves and Others for following countries / regions to its store: - North America...

Robotic Angioplasty Tool Saves Surgical Teams From Radiation

2012-07-26 12:28:36

John Neumann for redOrbit.com - Your Universe Online The FDA has granted clearance for the first robotic-assisted percutaneous coronary intervention (PCI) system to be used by surgeons. The CorPath 200, from Massachusetts-based Corindus Vascular Robotics provides robotic assistance for heart surgeons that are performing angioplasty, reports Chris Kaiser for MedPage Today. Angioplasty restores blood flow to a blocked coronary artery by inflating a balloon in the artery, and implanting a...

Biosensors Reports Strong Sales and Profitability in the First Quarter of Fiscal Year 2013

2012-07-25 06:25:18

SINGAPORE, July 25, 2012 /PRNewswire-Asia/ -- Biosensors International Group, Ltd. ("Biosensors" or the "Company", Bloomberg: BIG SP; Reuters: BIOS.SI; SGX: B20), a developer, manufacturer and marketer of innovative medical devices, today announced financial results for its first fiscal quarter ended 30 June 2012 ("Q1 FY13"). Q1 FY13 Highlights: Total revenue of US$86.3 million, representing 51% year-on-year growth Interventional Cardiology Products ("IVP") sales, largely...

FDA Clears First Robotic-Assisted System for Coronary Artery Disease Stent Procedures

2012-07-25 02:31:13

NATICK, Mass., July 25, 2012 /PRNewswire/ -- Corindus Vascular Robotics, a leading developer of precision vascular robotics, today announced FDA 510(k) clearance has been granted for the CorPath 200 System to be used in percutaneous coronary interventions (PCI). The technology is now approved in the United States to assist interventional cardiologists in performing PCI, a procedure to restore blood flow to blocked arteries in patients with coronary artery disease (CAD). To view...

Biodegradable Stents Will Soon Become Commercially Available - A Dream Come True, According to Latest Market Research by RI Technologies

2012-07-17 23:00:03

RI Technologies' (http://www.researchimpact.com) exclusive market research update gives an insight into Global Stents and Biodegradable Stents market. The market is divided by Application into Coronary Arterial Stents, Peripheral Arterial Stents and Other; and by Biodegradable Material into Polymer and Metal. Hyderabad, AP (PRWEB) July 17, 2012 Global Biodegradable Stents market is projected to grow at a CAGR of about 70% through the analysis period 2015-2020. With research trials...